Muscle & Brawn 2.0 is live! New Tools, Voice Reader, Compound Index, Features and more on the way. Want to explore what’s new → Click Here
Independent & reader-supported — every article medically reviewed

Peptides / Immune peptides

110 In the index

Thymopentin TP5

A synthetic peptide that was studied in human trials and briefly sold (as Timunox) for immune support in conditions like HIV and eczema, before being discontinued. Trial data from that time showed some immune-boosting activity, but it never became a lasting, widely used treatment.

Also known as TP-5, Timunox

Effects Immune
Routes Subcutaneous
Legal status Prescription drug
WADA Not listed

Molecular Structure of C30H49N9O9

Drag to rotate · scroll to zoom

  • Carbon
  • Hydrogen
  • Nitrogen
  • Oxygen

PubChem has no 3D conformer for this molecule, so this is the flat structure.

Chemistry

Formula
C30H49N9O9
Molar mass
679.8
CAS
69558-55-0
PubChem CID
451417

Reported dosing

Clinical data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 50 mg per dose (as previously marketed, Timunox)
Reported range 30-50 mg, 1-3 times weekly
Route Subcutaneous injection
Frequency 1-3 times weekly (as previously marketed)
Duration Chronic (historical clinical use)

Was studied and briefly marketed (as Timunox) for immune support in conditions like HIV and eczema before being discontinued; not currently an approved or marketed product.

Where this comes from Historical clinical trial data (discontinued product)

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.